Main Article Content
Tuberculosis remains the major public health concern worldwide responsible for about 1.6 million deaths and 0.3 million co-infected with Human immunodeficiency virus (HIV) annually. Mycobacterium is the causative agent of tuberculosis infection and is transmitted principally through air when an infected person coughs, talks, sneezes etc. This infection can be diagnosed using different Microbiological, Molecular and Immunological techniques including, sputum smear microscopy, sputum culture, nucleic-acid amplification test (NAAT), genotyping assay, tuberculin skin test (TST), interferon-gamma release assay (IGRAs) etc. These techniques vary in sensitivity and specificity as well as the ease with which they are carried out. World Health Organisation (WHO) encourages the use of techniques that are sensitive, patient-friendly, and those which produce accurate results in any clinical setting world-wide. Hence, this review highlights smear microscopy and incorporation of more rapid and sensitive diagnostic techniques such as Gene Xpert, IGRAs and urinary antigen analysis in clinical setting in the detection of Mycobacterium. These techniques show high sensitivity, are less time consuming do not require a repeat for a single result, some are able to differentiate latent and active TB infections, and have the capacity to be used to screen people unable to expectorate. This review encourages the incorporation of smear microscopy, GeneXpert, IGRAs, urinary antigen analysis into routine laboratory diagnosis especially in high TB burden countries. It is believed that high level of sensitivity and less time used in producing results display by these techniques will yield reduction in mortality rate, decline in static nature of TB status and possibly zero TB 2020 proposed by WHO.
Gordon SV, Parish T. Microbe profile: Mycobacterium tuberculosis: Humanity’s deadly microbial foe. Microbiology. 2018;164:437-439.
Robert Koch. World of microbiology and immunology. Ed. Brenda Wilmoth Lerner and K. Lee Lerner. Detroit: Gale; 2006.
Ryan KJ, Ray C. Mycobacteria. Sherris medical microbiology: An introduction of infectious diseases (4th edition). New York: McGraw-Hill. 2004;439.
Christophe JQ, Roland B, Roxane S. The macrophage: A disputed fortress in the battle against Mycobacterium tuberculosis. Frontiers in Microbiology. 2017;8:2284.
MacLean E, Madhukar P. Urine lipoara-binomannan for tuberculosis diagnosis: Evaluation and prospects. Clinical Chemistry. 2018;64:8.
Ping C, Ming S, Guo-Dong F, Jia-yun L, Bing-ju W, Xiao-Dan S, Lei M, Xue-Dong L, Yi-Ning Y, Wen D, Ting-ting L, YingHe J, Xiao-ke H, Gang Z. A highly efficient ziehl-neelsen stain: Identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin. Microbiol. 2012;50(4):1166–1170.
Behera D. Pulmonary medicine. Japan Medical Journal. 2010;284.
Song SEJY, Leeks KH, Kim YM, Seongham KM, Suyeon J, Eunpvolee SP, Hee-jin K. Comparison of the tuberculin skin test and interferon gamma released assay for the screening of tuberculosis in adolescents in close contact with tuberculosis patients. Plos One Journal. 2014;9 (7):0100267.
Horvat RT. Gamma interferon assay used in the diagnosis of tuberculosis. J Clin. and Vaccine Immunology. 2015;22(8):845-849.
Gerald H, Mazurek MD, John Jereb MD, Andrew MD, Phillip LoBue MD, Stefan Goldberg MD, Kenneth Castro MD. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection United States. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, CDC. 2010;59(5):1-25.
Lalvani A, Richeld L, Kunst H. Comparison of interferon-gamma release assay versus tuberculosis. Lancet Infect. Dis. 2005;5(6):322-4.
Parsons ML, Akos SC, Guitierrez E, Evan L, Paramasian CN, Asash’le A, Steven S, Giorgio R, John N. Laboratory diagnosis of tuberculosis in resource-poor countries: Challenges and opportunities. J Clini. Microbiol. Review. 2011;24(2):314- 350.
Shneh S, Ranjan N, Trinad C. Clinical application of volatile organic compound analysis for detecting infectious diseases. Plos One Journal. 2013;26(3):462-475.
Xiao AF, Mingxiao L, Ralph JK, Michael HN, Michael B. Noninvasive detection of lung cancer using exhaled breath. J Cancer Medicine. 2013;3(1):174–181.
Saddiq TA, Omezikam M, Lawson L, Olanrewaju O, Mathew B, Joshua O, Russell D, Adams ER, Nnamdi E, Suvand S, Jacob C, Luis EC. Testing pooled sputum with Xpert MTB/RIF for diagnosis of pulmonary tuberculosis to increase affordability in low-income countries. Journal of Clin. Microbiol. 2015;53(8):2502-2508.
John R, Warren MB, kleper NF, de-almeida KT, Lance RP. A minimum 5.0 ml of sputum improves the sensitivity of acid-fast smear for Mycobacterium tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2000;5:161.
Louis G, Laura M, Robert HG, Teresa V, Beatriz H, Willi Q, Eric R, Maribel R, Rosario MA, Roderick E, David C, Denis M, Carlton AE. Tuberculosis diagnosis and multidrug resistance testing by direct sputum culture in selective broth without decontamination or centrifugation. J Clin. Microbiol. 2008;46(7):2339–2344.
Arzu NZ, Sezai T, Cengiz C. Evaluation of the genexpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin. Micro-bial. 2011;05434-11.
De keyser E, De keyser F, De Baets F. Tuberculosis skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta. Clin. Belg. 2014;69(5):358-66.